We investigatedthe "abnormal"sub-bandsof serumcreatine kinase (CK; EC 2.7.3.2) isoenzyme MM in acute myocardial infarction(AMI), using isoelectricfocusingin polyacrylamide gels, and compared the patterns with those for non-AMI patientsand for athleteswith increasedCK. The "abnormal" sub-bandsa (p17. We recently proposed (19) a serum CK-MM nomenclature that distinguished the three "normal" and 11 "abnormal" sub-bands seen in AM! patients and was consistent with the anodal direction of CK-MM conversion (19). We now evaluate the clinical significance of these "abnormal" sub-bands and demonstrate their fm-mation from the major "normal" sub-bands. 
Materials and Methods
Reagents. Acrylamide and N,N'-methylenebisacrylamide ("Electran") and p1 calibration proteins were purchased from BDH Chemicals, Poole, Dorset, U.K. Ampholytes ("Pharmalyte," pH 5-8) were from Pharmacia, Uppsala, Sweden. All solutions were freshly prepared with de-ionized water ("Elgastat" purification system).
Apparatus. For flat-bed isoelectric focusing (IEF) we used a power supply unit from LKB Instruments, Bromma, Sweden, and a Model 600 ehectrophoresis system from Shandon Southern Products Ltd., Runcorn, Cheshire, U.K.
Samples: Serum samples. Serum from venous blood, processed within 2 h of collection, was immediately assayed for total CK activity with a centrifugal analyzer (Cobas Bio; Hoffmann-La Roche & Co. Ltd., Baseh, Switzerland). CK isoenzymes (CK-MB) were determined (sometimes after storage at -20 #{176}C for as long as three days) with a Corning electrophoresis system as recommended by the manufacturer. Potassium EDTA (5 mmol/L) was added to stabilize the CK-MM sub-bands (12) and the sera were stored in liquid nitrogen (19) until JEF. Samples were obtained from:
.74 AM! patients (45 men, 29 women; ages 42-87 y), diagnosed on the basis of clinical history, electrocardiography, and changes in serum lactate dehydrogenase/CK activity (24) . The location of the infarction was inferior in 50% of the patients, anterior in 39%, and global (with inferior and anterior wall changes) in 11%; 23% had a history of AM!, 26% had angina, and 12% died within the next four months. None of these patients received thrombolytic therapy. Samples were routinely obtained on hospital admission and 12 and 36 h later but also at 6-h intervals for three days after admission (12 patients) or daily for nine days (10 patients). The time of infarct was judged to be from the onset of severe chest pain.
19 non-AMI patients (11 men, eight women; ages 41-84 y), hospitalized with chest pain but diagnosed as not having AM! by the above criteria. This group included a 62-year-old woman with polymyositis and patients with cardiac arrest, ischemic heart disease, papillary muscle dysfunction, atrial fibrillation, left bundle-branch block, acute pulmonary edema, hypertension, or seizures (post-ictal state). Samples were routinely collected at the time of hospital admission and 12 and 36 h later, but occasionally at 6-h or daily intervals as described above. Twelve of these patients had increased CK, and sequential sampling indicated its concentration to be increasing in five, decreasing in five, and static in two. The remaining seven patients (predominantly angina) had normal values for total CK.
. 14 athletes (13 men, one woman; ages 22-45 y), sampled 24-60 h before and 24 and 48 h after a triathlon (2 km swimming, 90 km bicycling, 21 km marathon running).
Tissue samples. Myocardial slices obtained at autopsy (24-48 h after death) and stored frozen were rinsed in water, dissected, and homogenized (1.3-g aliquots) in 10 mL of either (a) heat-inactivated (60 #{176}C, 30 mm) normal serum with low CK content, or (b) Tris HC1 buffer (100 mmol/L, pH 8) containing 5 mniol of dithiothreitoh per liter (21) . We then centrifuged (2000 x g, 10 mm) the homogenates and diluted the supernates with isotonic saline (NaCl, 150 mmol/L) to give a final CK activity of 1000 UIL. In vitro incubations. We incubated the serum samples at room temperature for 15 
Results
Our serum CK-MM nomenclature is shown in Figure 1 7.05), f (p1 6.72), and h (p1 6.40) were detected only when sub-bands a and (or) b were prominent. The total serum CK (and % CK-MB) of patients demonstrating sub-band b was not atypical of the other AMI patients, but these patients were more likely to be smokers (79%) with a family history of ischemic heart disease (58%) and a personal history of AM! (37%) than were the other 55 AMI patients (respective values 60%, 19%, and 21%). Furthermore, 63% of these infarcts were inferior in location (26% anterior; 11% global), whereas only 28% of those lacking sub-band b were inferior (61% anterior; 11% global). The three patients demonstrating CK-MM sub-band a were smokers and two had diabetes mellitus; their prognosis was poor and two died. The changes in the serum CK-MM sub-band pattern after AM! are shown in Figures 1-3 . An initial cathodal shift in subband distribution (CK-MM 1>2>3; c>e>g; Figure 2A, 3) , with simultaneous appearance of a and (or) b if present, accompanied the increase in total serum CK between 3 and 12 h after infarction and was not detected unless patients were quickly hospitalized (Figure 1, 28) . This was followed, between 24 and 36 h after infarction, by the widely reported anodal shift (CK-MM 1<2<3; c<e<g), with simultaneous loss of a and (or) b if present, and diffuse appearance of subbands i, j, and sometimes k (Figures 1-3) . Normalization of the pattern continued after the total serum CK had declined and stabilized. It occurred in a step-wise fashion; i.e., subbands 1 and c normalized within two days, followed by 2 and e (three days), then 3 and g (seven days), and finally j (nine days) (Figure 28 ). The CK-MM sub-band patterns before with angina who suffered a massive global AM! about 8 h after admission ( Figure 3A) . The effect of re-infarction is evident from Figure 38 ; i.e., the anodal shift was reversed, with intensification of sub-bands 1 and c before further anodal conversion.
The serum CK-MM sub-band patterns of non-AM! patients with increased total serum CK (and %CK-MB) resembled those of AM! with prominent detection of CK-MM 1-3 and the "abnormal" sub-bands c, e, and g (Figure 4 ). However, a and b were not detected, nor were d, f, and h clearly distinguished (Figure 4) , even when total serum CK exceeded 31 000 U/L (%CK-MB = 20%). The sub-band distribution pattern was generally more uniform (CK-MM 1 = 2 = 3; c = e = g = j) than in AMI and usually remained so upon sequential sampling; i.e., the anodal distribution changes, characteristic of AM!, were far less pronounced ( Figure 4A ) and "normalization" in the patient with polymyositis involved a gradual and uniform decrease in subband intensity (Figure 48) . 11-13, 16, 19) is the predominant isoform in tissue (15, 27) The molecular basis of the conversion between CK-MM 1-3 and b-g is unknown, but it merits urgent investigation because the biochemical agents involved could govern AM! survival or even be indicative of AMI susceptibility in highrisk groups. The 2-mercaptoethanol effect suggests sequential conformational changes in the CK structure (perhaps involving monomer-dimer interchange) or sequential dieplacement of two molecules of an acidic thiol compound such as glutathione (glutamyl-cysteinyl-glycine).
